B-Cell Aging, Tolerance Failure, and Age-Associated B Cells (ABCs)
Current understanding
Aging is proposed to erode B cell-intrinsic central and peripheral tolerance checkpoints, and the resulting autoreactive B-cell output is then selectively amplified by the inflammaging cytokine milieu — notably expanding age-associated B cells (ABCs) and DN2 B-cell subsets that are adapted to chronic inflammatory signals and enriched in older adults with autoimmunity [expert-opinion]. This frames age-related autoimmunity as a two-step interaction between an intrinsic B-cell aging program and the systemic inflammatory environment rather than as either alone [expert-opinion]. Human-translation status: hypothesis-synthesis stage; no interventional evidence yet targeting ABC/DN2 expansion for aging or autoimmunity endpoints in humans.
Evidence log
- 2025-12-05 — The immuno-neurological axis: association between autoimmune diseases and dementia risk.: cross-connection with inflammaging: The autoimmunity → dementia association in a large Korean cohort offers population-scale downstream evidence for the two-step B-cell-intrinsic-aging-meets-inflammaging model: tolerance erosion plus sustained inflammatory tone could plausibly contribute to Alzheimer’s-type neurodegeneration risk. (novelty: 3)